Literature DB >> 9811804

DSHP: a "power bar" for sustained immune responses?

A B Satterthwaite1, D J Rawlings, O N Witte.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9811804      PMCID： PMC33915          DOI： 10.1073/pnas.95.23.13355

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  40 in total

Review 1.  Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus.

Authors:  A F List; F A Greco; L B Vogler
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

2.  p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.

Authors:  M N Lioubin; P A Algate; S Tsai; K Carlberg; A Aebersold; L R Rohrschneider
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

Review 3.  The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?

Authors:  A M Scharenberg; J P Kinet
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

4.  Epstein-Barr virus and the immune system. Hide and seek.

Authors:  J I Cohen
Journal:  JAMA       Date:  1997-08-13       Impact factor: 56.272

5.  Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.

Authors:  M D Ware; P Rosten; J E Damen; L Liu; R K Humphries; G Krystal
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

6.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Authors:  D H Hsu; R de Waal Malefyt; D F Fiorentino; M N Dang; P Vieira; J de Vries; H Spits; T R Mosmann; K W Moore
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

Review 7.  X-linked lymphoproliferative disease: twenty-five years after the discovery.

Authors:  T A Seemayer; T G Gross; R M Egeler; S J Pirruccello; J R Davis; C M Kelly; M Okano; A Lanyi; J Sumegi
Journal:  Pediatr Res       Date:  1995-10       Impact factor: 3.756

8.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.

Authors:  L E Marengère; P Waterhouse; G S Duncan; H W Mittrücker; G S Feng; T W Mak
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

10.  X chromosome inactivation patterns in obligate carriers of X-linked lymphoproliferative syndrome.

Authors:  M E Conley; J L Sullivan; J A Neidich; J M Puck
Journal:  Clin Immunol Immunopathol       Date:  1990-06
View more
  1 in total

1.  A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.

Authors:  Peter M Hwang; Chengjun Li; Massimo Morra; Jennifer Lillywhite; D Ranjith Muhandiram; Frank Gertler; Cox Terhorst; Lewis E Kay; Tony Pawson; Julie D Forman-Kay; Shun-Cheng Li
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.